
Measles vaccination rate may be even lower than estimated, leaving kids vulnerable amid outbreak
As the United States faces one of its worst measles outbreaks in decades, a new analysis finds that nearly a third of young children who were eligible to be vaccinated against the disease did not get their first shot on schedule.
Measles is an extremely contagious airborne disease that can be especially dangerous for young and unvaccinated children. The measles-mumps-rubella (MMR) vaccine is highly effective, with one shot offering 93% protection against measles and a second shot raising it to 97%. The first dose is recommended between 12 and 15 months of age and the second dose between ages 4 and 6.
In 2024, just 68.5% of children in the US had received their first dose by 15 months of age, according to a new report from Truveta, a health-care data and analytics company. This is a marked decline from 2020, when more than 77% of children had received their first shot by this age.
'The pool of children that could get really sick, could have severe complications and possibly die, has been bigger each year since Covid,' said Dr. Nina Masters, a senior research scientist at Truveta and former epidemiologist at the US Centers for Disease Control and Prevention. 'Especially among these outbreaks, it's just a very troubling thing to see in the data.'
The US Department of Health and Human Services has set a goal that at least 95% of children in kindergarten will have gotten two doses of the MMR vaccine, a threshold necessary to help prevent outbreaks of measles.
But leaving more than 30% of a particularly vulnerable population of young children without any protection from one dose creates unnecessary risk, experts say.
'Don't delay, and particularly not now,' Dr. Ashish Jha, dean of the Brown University School of Public Health who was federal Covid-19 response coordinator in the Biden administration, advises parents.
At least 565 cases of measles have been reported in the US this year, according to a CNN tally using data from the CDC and state health departments. It's only the third year with more than 500 cases since measles was declared eliminated in the country a quarter-century ago.
Oklahoma Sen. James Lankford downplays concerns over RFK Jr.'s handling of the worsening measles outbreak but urges people to get vaccinated. In Texas, the epicenter of the current outbreak, at least a third of all reported cases have been among children younger than 5, according to data from the state health department. Nearly all were unvaccinated.
'Once you get below 95% [vaccination], the ability of that virus to start circulating in the community goes up substantially,' Jha said. 'Even small decreases in the percentage of school-age kids being vaccinated could mean much bigger outbreaks in terms of the number of children who are involved.'
Undervaccinated pockets of the US create broader vulnerabilities, he said. When eligible children are not vaccinated, it creates a greater risk that the virus will reach those who are too young to be vaccinated.
'It's essentially like dry timber waiting to be lit on fire,' Jha said. 'What you have is just a lot of vulnerable communities around America. And I think we're sort of playing Russian roulette here with these outbreaks, because obviously, people don't stay local.'
The new Truveta report also highlights the divide between vaccination rates for children in urban areas, where 75% of children had gotten a dose of MMR by 15 months of age, and rural areas, where only 65.5% of kids had gotten the shot.
The reasons for this disparity can be 'divided into structural barriers and then vaccine hesitancy,' said Dr. Catherine Troisi, infectious disease epidemiologist with UTHealth Houston.
In rural areas, there might be fewer medical providers in general, and people may have to travel father to get vaccinated, she said.
Troisi said studies show that in rural areas, there are also more people who 'may buy into some of the misinformation about immunizations.'
The Texas outbreak started in rural Gaines County, which now has 280 cases, according to the state health department, although experts say that is most likely a severe undercount.
Coverage with the MMR vaccine is particularly low in Gaines County, where nearly 1 in 5 incoming kindergartners in the 2023-24 school year had not gotten the shot. Some other counties affected by the outbreak – which now includes New Mexico, Oklahoma and possibly Kansas – also fall below the 95% vaccination benchmark.
Another new report from Truveta found that in 2024 just 80.4% of children had received two doses of the MMR vaccine by the time they turned 6, far lower than CDC estimates, which put coverage at just under 93% for kindergartners in the 2023-24 school year.
The data analyses capture two different populations, and 'likely the truth lies somewhere in the middle,' said Masters, who has studied measles for the past decade.
Truveta's database captures electronic health records for nearly a third of the US population and covers nearly a fifth of daily clinical care across the country, but the findings from its analysis of people seeking more regular primary care may not be fully representative of nationwide trends.
But vaccination data from the CDC is an estimate too, based on surveys with varying representation, none of which would capture the growing share of children who are homeschooled.
Other recent research also suggests that MMR vaccine coverage may be lower than federal data says.
A survey of nearly 20,000 parents between mid-2023 and mid-2024 found that just 71.8% said their children had gotten at least one dose of MMR vaccine by age 5, according to a study published last month in the American Journal of Public Health.
Although each analysis might differ in its approach, the consistent finding of declining vaccination rates is the most consequential takeaway, Masters said.
'Every analysis, every outbreak, always has the same conclusion that you end outbreaks with rapid, prompt mass vaccination. That's how you bring outbreaks under control,' she said. 'We're going in the wrong direction. We're not getting close to bringing this under control, and we're exposing a situation where there are more kids who are at risk instead of fewer.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
Novavax Stock (NVAX) Gets a Boost from ‘Robust Immune Responses'
Novavax (NVAX) stock jumped on Wednesday after the vaccine maker released results from a Phase 3 clinical trial of its COVID-19-Influenza Combination (CIC) and stand-alone flu vaccine. The initial cohort results from this study included 'robust immune responses' for the CIC and flu vaccine that were comparable to licensed rivals Nuvaxovid and Fluzone HD. Confident Investing Starts Here: Additionally, Novavax noted that the two vaccines were well tolerated. Almost all of the adverse events, greater than 98%, that were experienced by patients were mild or moderate in severity. The trial includes roughly 2,000 patients aged 65 or older. Novavax stated that it will continue to seek partners to further the development of its CIC and stand-alone flu vaccines. The results from this study provide it with the data it needs for discussions with potential partners. NVAX Stock Movement Today While NVAX stock had soared more than 2% in pre-market trading, the company couldn't maintain those gains. As a result, the stock is only up 0.56% as of Wednesday morning. Investors will also note that shares are down 8.83% year-to-date and 54.6% over the past 12 months. The Phase 3 clinical trial data also failed to attract investor interest today. Trading volume was muted at 1.38 million shares, compared to a three-month daily average of roughly 11.29 million units. Is Novavax Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Novavax is Hold, based on one Buy, two Hold, and a single Sell rating over the past three months. With that comes an average NVAX stock price target of $11.25, representing a potential 55.39% upside for the shares. Spark, TipRanks' AI analyst, highlighted 'strong revenue growth and profitability improvements' but warned of 'negative equity and cash flow challenges.'
Yahoo
an hour ago
- Yahoo
Editorial: Ax to the vax — RFK Jr. continues on his anti-vaccine warpath
It's time for President Donald Trump, despite his own casual relationship with the truth, to stop putting American lives at risk and get rid of his dangerous quack in chief, Health and Human Services Secretary Robert F. Kennedy Jr. In his latest broadside against science, Kennedy is removing all 17 members of the Advisory Committee for Immunization Practices, the CDC's main advisory body, to ostensibly restore 'public trust above any specific pro- or anti-vaccine agenda.' God protect us, as RFK won't. This is how a society becomes undone. Science and reason get stepped on by half-truths and conspiracy theories. Next comes preventable death and disease. The problem is that there is no anti-vaccine side in the legitimate practice of science and medicine. The department's accompanying press release denigrated 'public health ideology' as if the practice of public health wasn't the CDC's only function. Researchers and doctors should be biased in favor of evidence-based therapeutics that save lives. Railing against bias towards vaccines is like a politician condemning researchers biased in favor of seatbelts in cars or keeping lead out of household paint. It's idiotic. We understand that the Make America Healthy Again movement Kennedy leads is all about questioning medical and nutritional practice. On a really abstract level, we are in agreement that no scientific truisms should be entirely above questioning — such a perspective would be anti-science. But there is a specific and long-standing methodology for actually answering those questions, and it is not debate club or who can most incite crowds of followers. It is the scientific method, under which hypotheses can be rigorously tested in ways that are replicable and based on clear and clearly laid out evidence. In that arena — really the only arena that actually matters when it comes to public health — the safety and efficacy of vaccines has been conclusively established. There is no additional discussion necessary or appropriate, particularly when it comes to immunizations that have now been standard-issue for decades and have by all measures radically decreased illness and mortality where they've been successfully deployed. The measles vaccine will always be better for individuals and public health than getting the measles. The same is true for polio, tetanus, COVID and all else. Preying on public skepticism of the pharmaceutical and health industries to hawk alternative approaches that are often unregulated and don't work is damaging it enough. Yet a true believer like RFK is more dangerous, especially now that he stands at the pinnacle of our nation's public health bureaucracy, a position that allows him to substantively impose his own anti-science view on an unsuspecting public and take the choice away from the American people. If RFK's new picks for ACIP — which the secretary falsely promised Sen. Bill Cassidy he wouldn't touch during his confirmation process — step back from recommending various crucial vaccines, this could substantially prevent even those who want to make the informed decision to receive inoculations or have their children vaccinated from being able to do so. As much as Kennedy and his followers emphasize the need for people to be able to make individual choices about their health, they seem hell-bent on taking that choice away entirely, especially given that insurance is not required to cover vaccines that are not CDC-recommended. We wonder what RFK will have to say for himself as once-eradicated diseases begin cutting through the U.S. population again. Is there anything that will get him to veer off this disastrous course? If the answer is no, and we suspect it is, then he must be removed before he can further damage public health. _____
Yahoo
an hour ago
- Yahoo
WHO: New coronavirus variant seen only sporadically in Germany
The new coronavirus variant spreading globally, especially in parts of Asia, has not taken hold in Germany, according to the World Health Organization. The variant, known as NB.1.8.1, was first detected in January and has been classified by the WHO as a "variant under monitoring." In Germany, the variant was first detected at the end of March and has so far only appeared sporadically, according to the country's public health agency, the Robert Koch Institute (RKI). "No trend can be derived here; current Covid case numbers are low, and correspondingly less sequencing is being conducted," the institute stated. University of Basel biophysicist Richard Neher said whether this variant "will establish itself [in Germany] depends on how other variants evolve. It is quite possible that NB.1.8.1 will prevail, but it is likely to be relatively insignificant." In the most recent reporting week, which ended on June 8, the RKI recorded 698 Covid cases - a slight increase - but the institute noted this is off a very low base. Many infections are likely going undetected due to limited testing. Slight increase in virus load in wastewater Wastewater monitoring also showed a slight increase in SARS-CoV-2 levels over the past four weeks – albeit still at a low level. The new NB.1.8.1 strain is derived from the XDV.1.5 lineage dominant in East Asia, according to biophysicist Neher. The state-run Chinese news agency Xinhua, citing the National Administration of Disease Control and Prevention, reported that the new strain had become China's dominant variant by the end of May. "The variant is increasing in frequency compared to other variants," Neher noted. NB.1.8.1 is therefore more transmissible in the sense that an infection generates more secondary infections than other strains. No evidence of more severe cases There is no evidence that NB.1.8.1 causes more severe illness, Chinese authorities have said. This aligns with the WHO's assessment that, despite rising case and hospitalization numbers in countries where the variant is widespread, there is currently no indication that it causes more serious illness than other circulating variants. Covid-19 vaccines currently approved are expected to protect against severe illness caused by NB.1.8.1, the WHO said.